Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia, Lymphocytic, Chronic, B-Cell 20Hodgkin Disease 19Myelodysplastic Syndromes 18Lymphoma, Non-Hodgkin 16Myeloproliferative Disorders 14Lymphoma, Mantle-Cell 14Leukemia, Myelomonocytic, Chronic 14Multiple Myeloma 13Lymphoma, Large B-Cell, Diffuse 12Leukemia, Myeloid, Chronic-Phase 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Leukemia, Prolymphocytic 10Waldenstrom Macroglobulinemia 9Lymphoma, Follicular 9Lymphoma, B-Cell, Marginal Zone 9Lymphoma 8Burkitt Lymphoma 8Anemia, Refractory, with Excess of Blasts 8Myelodysplastic-Myeloproliferative Diseases 7Leukemia, Biphenotypic, Acute 7Primary Myelofibrosis 6Leukemia 6Recurrence 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large-Cell, Anaplastic 5Graft vs Host Disease 5Congenital Abnormalities 5Blast Crisis 5

Interventions

Tacrolimus 1Phlebotomy 1Cyclosporins 1Cyclosporine 1Blood Specimen Collection 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymic aplasia × Cyclosporins × Clear all
NCT02274662 2025-01-16

Expanded Access Protocol Thymus Transplantation

Sumitomo Pharma Switzerland GmbH

Phase 4 Completed
11 enrolled 10 charts

Thymic aplasia, Immunologic Deficiency Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡